Contraceptive Patch

Afaxys Pharma is proud to be an authorized promotional partner for Twirla® (levonorgestrel and ethinyl estradiol) to help bring you additional contraceptive offerings for your patients. Click the product below to learn more.


Twirla

Twirla®

(levonorgestrel and ethinyl estradiol) transdermal system 120 mcg/day levonorgestrel and 30 mcg/day ethinyl estradiol

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS and CONTRAINDICATED IN WOMEN WITH A BMI ≥30 kg/m2

Cigarette Smoking and Serious Cardiovascular Events
Cigarette smoking increases the risk of serious cardiovascular events from combined hormonal contraceptive (CHC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, CHCs, including TWIRLA, are contraindicated in women who are over 35 years of age and smoke.

Contraindicated in Women with a BMI ≥30 kg/m2
TWIRLA is contraindicated in women with a BMI ≥30 kg/m2. Compared to women with a lower BMI, women with a BMI ≥30 kg/m2 had reduced effectiveness and may have a higher risk for venous thromboembolic events (VTEs).

Learn More View Full Prescribing Information, Including Boxed Warning

Visit the TWIRLA website here.


Need help? Contact an Afaxys Account Manager